Bristol-Myers, Nektar Developing Cancer Therapy to Be Used with Checkpoint Inhibitors – Immuno-Oncology News
Immuno-Oncology News |
Bristol-Myers, Nektar Developing Cancer Therapy to Be Used with Checkpoint Inhibitors
Immuno-Oncology News They will test the combo in advanced non-small cell lung cancer, kidney cancer, bladder cancer, melanoma, and triple negative breast cancer. “Bristol-Myers Squibb, the global leader in immuno-oncology [cancer immunotherapy], is the ideal collaborator … |
